is mounjaro a glp 1 agonists vs Ozempic- Key Differences & Outcomes GLP-1 Agonists for Diabetes: Mounjaro

289 The rise in cAMP activates PKA, a versatile protein kinase that phosphorylates various target proteins

Additionally, GLP-1 agonists consistently reduced the risk of visual disturbances and refractory IIH, with statistically significant effects sustained up to 24 months, demonstrating a sustained benefit throughout the treatment period

Lets say youve been on a higher dose, and it took you five months to build up to that dose

Wei H, Bu R, Yang Q, Jia J, Li T, Wang Q, Chen Y

R., Basha S., Jain R., Shetty S., and Ramachandran A., Exenatide and Acute Pancreatitis, Journal of the Association of Physicians of India 56 (2008): 987988